Technology | 2019.06.20
BD Statement on FDA Circulatory System Devices Panel Regarding Paclitaxel-Coated Devices
FRANKLIN LAKES, N.J., June 20, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement following the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel of the Medical...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]-coated-devices-300872436.html
